Matches in Wikidata for { <http://www.wikidata.org/entity/Q90447261> ?p ?o ?g. }
- Q90447261 description "article scientifique publié en 2019" @default.
- Q90447261 description "artículu científicu espublizáu en marzu de 2019" @default.
- Q90447261 description "im März 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90447261 description "scientific article published on 01 March 2019" @default.
- Q90447261 description "wetenschappelijk artikel" @default.
- Q90447261 description "наукова стаття, опублікована 1 березня 2019" @default.
- Q90447261 name "Cost-effectiveness and Budgetary Consequence Analysis of Durvalumab Consolidation Therapy vs No Consolidation Therapy After Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer in the Context of the US Health Care System" @default.
- Q90447261 name "Cost-effectiveness and Budgetary Consequence Analysis of Durvalumab Consolidation Therapy vs No Consolidation Therapy After Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer in the Context of the US Health Care System" @default.
- Q90447261 type Item @default.
- Q90447261 label "Cost-effectiveness and Budgetary Consequence Analysis of Durvalumab Consolidation Therapy vs No Consolidation Therapy After Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer in the Context of the US Health Care System" @default.
- Q90447261 label "Cost-effectiveness and Budgetary Consequence Analysis of Durvalumab Consolidation Therapy vs No Consolidation Therapy After Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer in the Context of the US Health Care System" @default.
- Q90447261 prefLabel "Cost-effectiveness and Budgetary Consequence Analysis of Durvalumab Consolidation Therapy vs No Consolidation Therapy After Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer in the Context of the US Health Care System" @default.
- Q90447261 prefLabel "Cost-effectiveness and Budgetary Consequence Analysis of Durvalumab Consolidation Therapy vs No Consolidation Therapy After Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer in the Context of the US Health Care System" @default.
- Q90447261 P1433 Q90447261-89B406CA-3999-4EB9-B674-C1B0E42CA6CC @default.
- Q90447261 P1476 Q90447261-9E5F9B4E-E50D-4A41-9A68-EC92D7DBA8EE @default.
- Q90447261 P2093 Q90447261-2DF5F096-B5E6-4129-95F3-49E1E3E4A665 @default.
- Q90447261 P2093 Q90447261-A80D77B9-B7B8-490F-9345-5148F067497E @default.
- Q90447261 P2093 Q90447261-B6AE4B6C-8138-4007-951B-9B2BFCA37907 @default.
- Q90447261 P2093 Q90447261-CAB29F81-A239-448F-983E-4DE136F586CF @default.
- Q90447261 P2093 Q90447261-D1F22418-78B5-43DE-83C8-A2E30F3D8028 @default.
- Q90447261 P2093 Q90447261-DDE54071-168F-43DC-BA0A-D774A3BF750D @default.
- Q90447261 P2093 Q90447261-E1FDAA6A-8ED2-47E4-BCF8-0B73582CCAF4 @default.
- Q90447261 P2860 Q90447261-0106F124-7067-4050-991A-86C6A5BAE909 @default.
- Q90447261 P2860 Q90447261-099942CF-7B97-41BB-8402-B732F0F97307 @default.
- Q90447261 P2860 Q90447261-0B3E5A9D-3B18-4C7C-A9CB-A00979B95C0D @default.
- Q90447261 P2860 Q90447261-1255C255-7BD8-4DC0-ABCD-7B3AAFB15EBA @default.
- Q90447261 P2860 Q90447261-2329E86C-0169-4CC8-AC3A-5A58527FD0DA @default.
- Q90447261 P2860 Q90447261-3617C453-B93C-413C-A772-E5ADA6680451 @default.
- Q90447261 P2860 Q90447261-3E09E870-B73E-46A5-88D0-E1CA2C5835ED @default.
- Q90447261 P2860 Q90447261-43888E2D-CA02-43E0-B1C9-F7CC94C7358C @default.
- Q90447261 P2860 Q90447261-468F6735-7756-4F68-B7C0-43C34A007E30 @default.
- Q90447261 P2860 Q90447261-48554093-AB8C-4B22-93E4-C857EC793989 @default.
- Q90447261 P2860 Q90447261-5289F6BA-1161-4A2D-84DB-09D027A03B6E @default.
- Q90447261 P2860 Q90447261-54775D86-B4B2-4205-8F30-DECD96B4E4D3 @default.
- Q90447261 P2860 Q90447261-597D72C8-2C46-43C6-AE6E-3CC7BBE67BBF @default.
- Q90447261 P2860 Q90447261-773C4D52-0825-43D3-809F-79F8B78C37C4 @default.
- Q90447261 P2860 Q90447261-91360FDF-0A84-4658-B454-29BC1A3536B0 @default.
- Q90447261 P2860 Q90447261-9241981E-6A9F-4ECC-8C6C-551DE2F2937E @default.
- Q90447261 P2860 Q90447261-9269E3AB-4EFC-4469-8B20-9A37230CCF8F @default.
- Q90447261 P2860 Q90447261-9E52D203-6F51-4899-9CF4-EC268369166E @default.
- Q90447261 P2860 Q90447261-A19CC500-5FC3-4C63-9962-E0A52A989D31 @default.
- Q90447261 P2860 Q90447261-C0DDE9AF-B1F9-4DD0-B9D2-2E9F22DA48EC @default.
- Q90447261 P2860 Q90447261-D67EE40F-8B07-4201-86B7-3DADFFDB6619 @default.
- Q90447261 P2860 Q90447261-E0D6CB8C-A080-4DC9-8951-AD705B2330D0 @default.
- Q90447261 P2860 Q90447261-E63FC6C9-B0BC-4240-9CCE-D4AA3043CB57 @default.
- Q90447261 P2860 Q90447261-E8B968A2-9740-4BF2-96D5-D7B727A23240 @default.
- Q90447261 P2860 Q90447261-E9BBDE87-96E5-45ED-91BC-5CF2CA6F1230 @default.
- Q90447261 P2860 Q90447261-F361AA87-9A26-4D90-88C4-8686F57C7D78 @default.
- Q90447261 P2860 Q90447261-F3A6365A-1D55-4553-AE02-ACBB0067B62F @default.
- Q90447261 P304 Q90447261-73B30935-F611-4020-A692-447BAF1473A4 @default.
- Q90447261 P31 Q90447261-41DC0DC9-EF21-4C9E-8F21-9EF21925F076 @default.
- Q90447261 P356 Q90447261-E1792E06-610B-4513-880D-8D622B4183C2 @default.
- Q90447261 P433 Q90447261-DA0007CE-68BA-480E-BAA1-91358910DD10 @default.
- Q90447261 P478 Q90447261-4A3B3DF4-2C82-4D7C-9F4A-DCB30A5C9F81 @default.
- Q90447261 P50 Q90447261-934130BF-2AA0-46D1-8CD9-1D5AABFD590D @default.
- Q90447261 P577 Q90447261-860BD2EE-3E51-42C5-BA30-0A4874A5FEBC @default.
- Q90447261 P698 Q90447261-93B215A6-6B43-4361-847D-14848D6F250B @default.
- Q90447261 P921 Q90447261-9EC69604-71E1-4DCE-82B8-FFBEF173E393 @default.
- Q90447261 P932 Q90447261-0E28B385-18DF-482A-A142-C605B0828F32 @default.
- Q90447261 P356 JAMAONCOL.2018.5449 @default.
- Q90447261 P698 30543349 @default.
- Q90447261 P1433 Q22079683 @default.
- Q90447261 P1476 "Cost-effectiveness and Budgetary Consequence Analysis of Durvalumab Consolidation Therapy vs No Consolidation Therapy After Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer in the Context of the US Health Care System" @default.
- Q90447261 P2093 "Chung Yin Kong" @default.
- Q90447261 P2093 "Deirdre F Sheehan" @default.
- Q90447261 P2093 "Justin F Gainor" @default.
- Q90447261 P2093 "Kerry L Reynolds" @default.
- Q90447261 P2093 "Leyre Zubiri" @default.
- Q90447261 P2093 "Meghan J Mooradian" @default.
- Q90447261 P2093 "Melissa A Lumish" @default.
- Q90447261 P2860 Q29615476 @default.
- Q90447261 P2860 Q29620902 @default.
- Q90447261 P2860 Q29620913 @default.
- Q90447261 P2860 Q30784508 @default.
- Q90447261 P2860 Q38093984 @default.
- Q90447261 P2860 Q38447643 @default.
- Q90447261 P2860 Q38716909 @default.
- Q90447261 P2860 Q38722972 @default.
- Q90447261 P2860 Q38815250 @default.
- Q90447261 P2860 Q38975751 @default.
- Q90447261 P2860 Q39016355 @default.
- Q90447261 P2860 Q39268069 @default.
- Q90447261 P2860 Q39677403 @default.
- Q90447261 P2860 Q40163779 @default.
- Q90447261 P2860 Q40408396 @default.
- Q90447261 P2860 Q44399058 @default.
- Q90447261 P2860 Q47191906 @default.
- Q90447261 P2860 Q47570767 @default.
- Q90447261 P2860 Q47834638 @default.
- Q90447261 P2860 Q49994910 @default.
- Q90447261 P2860 Q50055419 @default.
- Q90447261 P2860 Q51799211 @default.
- Q90447261 P2860 Q51914599 @default.
- Q90447261 P2860 Q52586557 @default.
- Q90447261 P2860 Q52586565 @default.
- Q90447261 P2860 Q59059822 @default.
- Q90447261 P2860 Q88973544 @default.
- Q90447261 P304 "358-365" @default.
- Q90447261 P31 Q13442814 @default.
- Q90447261 P356 "10.1001/JAMAONCOL.2018.5449" @default.